Dublin, March 04, 2024 (GLOBE NEWSWIRE) — The “Respiratory Endotherapy Devices Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” report has been added to ResearchAndMarkets.com’s offering.
New research on the Global Respiratory Endotherapy Devices Market has been released, providing an in-depth analysis of the market landscape over a ten-year forecast period. The market, valued at USD 1.45 Billion in 2022, is projected to witness a steady compound annual growth rate of 5.33% through to 2028.
Market dynamics have been significantly influenced by the healthcare challenges posed by the COVID-19 pandemic. The report details how this period of heightened demand led to strategic developments and government initiatives, such as a USD 75 million funding boost approved by the Global Fund to support India’s fight against the crisis in May 2021.
Rising Incidence of Respiratory Disorders and Shift Towards Minimally Invasive Procedures Boost Market Growth
According to the report, key factors such as the rising prevalence of respiratory disorders and the shift towards minimally invasive procedures are driving the market expansion.
With a global rise in chronic respiratory conditions, there is an increased demand for advanced endotherapy devices offering minimally invasive solutions. This has resulted in a plethora of innovations within the market, including advanced bronchoscopic and tracheoscopic tools that not only improve patient outcomes but also encourage rapid technology adoption among healthcare providers.
Collaborative Efforts Pave Way for Market Advancements
Strategic collaborations and partnerships have been fueling the market’s growth, enabling research and development endeavors to accelerate the creation of novel solutions, and aiding in market penetration. These alliances among market players, healthcare institutions, and research organizations have been crucial for initiating a combined response to the growing demand for respiratory therapeutic interventions.
The report highlights several challenges, among which the high cost of respiratory endotherapy devices and infection control concerns are paramount. Rising costs present barriers to entry for some healthcare providers, with sterilization and safety protocols further contributing to operational costs.
Trends Forward: Technological Advancements and AI Integration
Technological advancements in minimally invasive procedures and the integration of artificial intelligence and robotics are set to play a transformative role in the market. Advancements in high-definition imaging and navigation systems are improving the precision of interventions, with robotics amplifying this effect by providing enhanced operational control during procedures.
Segmental and Regional Insights
The segment-wise analysis indicates a significant growth expected in the Diagnostic Devices sector, underlining its critical position in early disease identification and management. In terms of end-user insights, Hospital Pharmacies are seen as crucial settings for effective disease treatment delivery.
Regionally, North America commands a dominant market position, attributed to its advanced healthcare infrastructure, making it an epicenter for cutting-edge research, treatment solutions, and adoption.
The comprehensive report provides a detail-oriented perspective on the market’s categorical sub-divisions and the respective influential factors at play. It serves as an essential resource for stakeholders within the Global Respiratory Endotherapy Devices Market, highlighting the avenues for growth and the areas of concern that require strategic focus.
As the market for Global Respiratory Endotherapy Devices continues to evolve, key market insights and trends outlined in this new report are expected to aid industry professionals and stakeholders in making informed decisions for the years ahead.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 179 |
| Forecast Period | 2022 – 2028 |
| Estimated Market Value (USD) in 2022 | $1.45 Billion |
| Forecasted Market Value (USD) by 2028 | $1.96 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
Report Scope:
In this report, the Global Respiratory Endotherapy Devices Market has been segmented into the following categories:
Respiratory Endotherapy Devices Market, By Devices:
- Diagnostic Devices
- Therapeutic Devices
Respiratory Endotherapy Devices Market, By End User:
- Peripheral Vascular Intervention
- Endovascular Interventions
- Cardiac
- Interventional Radiology
- Venous
- Others
Respiratory Endotherapy Devices Market, By Specialist:
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
Company Coverage:
- Fujifilm Holdings
- Medtronic
- Johnson & Johnson.
- Smith & Nephew
- Stryker
- Olympus
- Hoya
- Steris Healthcare
- Conmed
- Boston Scientific
For more information about this report visit https://www.researchandmarkets.com/r/54no3j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Respiratory Endotherapy Devices Market
